THERAPEUTIC BENEFITS OF 5-HYDROXYTRYPTAMINE INHIBITION FOLLOWING PULMONARY-EMBOLISM

被引：57

作者：

HUVAL, WV

MATHIESON, MA

STEMP, LI

DUNHAM, BM

JONES, AG

SHEPRO, D

HECHTMAN, HB

机构：

[1] BRIGHAM & WOMENS HOSP,DEPT SURG,BOSTON,MA 02115

[2] BRIGHAM & WOMENS HOSP,DEPT RADIOL,BOSTON,MA 02115

[3] HARVARD UNIV,SCH MED,BOSTON,MA 02115

[4] BOSTON UNIV,CTR BIOL SCI,BOSTON,MA 02215

来源：

关键词：

D O I：

10.1097/00000658-198302000-00016

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

引用

页码：220 / 225

页数：6

共 50 条

[1] THERAPEUTIC BENEFITS OF 5-HT INHIBITION FOLLOWING PULMONARY-EMBOLISM
HUVAL, WV
STEMP, LI
MATHIESON, MA
DUNHAM, BM
SHEPRO, D
HECHTMAN, HB
[J]. SURGICAL FORUM, 1982, 33 : 262 - 264
[2] PULMONARY EMBOLISM AND 5-HYDROXYTRYPTAMINE
不详
[J]. LANCET, 1956, 270 (05): : 240 - 240
[3] PULMONARY EMBOLISM AND 5-HYDROXYTRYPTAMINE
CARTER, K
[J]. LANCET, 1956, 270 (14): : 446 - 446
[4] PULMONARY-EMBOLISM - THERAPEUTIC DILEMMA
不详
[J]. LANCET, 1981, 2 (8260): : 1396 - 1396
[5] PULMONARY-EMBOLISM - THERAPEUTIC ASPECTS
YOSHINO, MK
MORENO, MJC
KNIBEL, MF
POLISUK, J
[J]. REVISTA BRASILEIRA DE MEDICINA, 1980, 37 (12) : 611 - 614
[6] INHIBITION OF CHOLINESTERASE BY 5-HYDROXYTRYPTAMINE
MOHAMMED, YS
OSMAN, MY
GABR, Y
[J]. ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1975, 25 (11): : 1714 - 1715
[7] PULMONARY-EMBOLISM - CURRENT THERAPEUTIC CONCEPTS
TIBBUTT, DA
CHESTERMAN, CN
[J]. DRUGS, 1976, 11 (03) : 161 - 192
[8] STUDY OF THE ROLE OF 5-HYDROXYTRYPTAMINE (SEROTONIN) AND HISTAMINE IN THE PATHOGENESIS OF PULMONARY EMBOLISM IN MAN
STONE, HH
NEMIR, P
[J]. ANNALS OF SURGERY, 1960, 152 (05) : 890 - 900
[9] PRESENT THERAPEUTIC STRATEGY IN PULMONARY-EMBOLISM
BROCHIER, M
RAYNAUD, P
CHARBONNIER, B
GRIGUER, P
[J]. INTERNATIONAL ANGIOLOGY, 1984, 3 (04) : 383 - 387
[10] THERAPEUTIC APPROACH TO ACUTE PULMONARY-EMBOLISM
PHILIPPOTEAU, C
GIRARD, P
MUSSET, D
BRIDEY, F
MILLAT, B
PETITPRETZ, P
SIMONNEAU, G
DUROUX, P
[J]. JOURNAL DES MALADIES VASCULAIRES, 1989, 14 (03) : 213 - 215